Amedisys Target Price

See how AMED's target price trends over time vs similar companies.

Get informed when a big investor buys or sells

+ Follow

Share Price

$100.99

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2024-03-25	RBC CapitalFrank Morgan	$100	1% downside
2023-07-06	JefferiesBrian Tanquilut	$90.8	10.1% downside
2023-01-05	Leerink Partners	$85	15.8% downside
2022-11-11	Stephens	$106	5% upside
2022-07-26	Truist FinancialDavid MacDonald	$150	48.5% upside
2022-07-03	Deutsche BankJustin Bowers	$175	73.3% upside
2022-04-29	Credit Suisse	$182	80.2% upside
2022-04-29	Raymond James	$180	78.2% upside
2022-04-29	Leerink Partners	$131	29.7% upside
2022-02-25	BMO CapitalMatthew Borsch	$190	88.1% upside
2022-02-25	RBC CapitalBen Hendrix	$199	97% upside
2022-02-24	Deutsche BankJustin Bowers	$230	127.7% upside
2022-02-24	Benchmark Co.Bill Sutherland	$175	73.3% upside
2021-11-04	StephensScott Fidel	$185	83.2% upside

Amedisys (AMED) FAQ

Stockcircle tracks target price for Amedisys (AMED), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Amedisys's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main AMED overview so you can move from this figure to the surrounding analysis quickly.